24/7 Patient Assistance: 760-405-8205

Weijing Sun, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer

specialties & services

  • Bio & Insurance Information

    Dr. Weijing Sun graduated medical school from Shanghai Medical University and completed his residency at Loyola University. A fellowship in hematology/oncology followed at University of Pennsylvania Health System. Dr. Sun is specialized and board certified in medical oncology. He has been in practice for more than 20 years and is affiliated with University of Pittsburgh Medical Center. Moreover, during his career, he has run multiple clinical trials and has published several writings of medical interest in collaboration with other doctors.

  • Education & Training


    Shanghai Medical University Graduated in 1982

    Medical School


    Loyola University Med Center Completed in 1996



    Loyola University Med Center Completed in 1998



    Perelman School of Medicine University of Pennsylvania Completed in 2001


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Magee Womens Hospital of UPMC Pittsburgh

    Languages: English/Spanish

    (412) 641-1000

    300 Halket St

    Pittsburgh, Pennsylvania 15213

    Read More

    UPMC Presbyterian Shadyside

    Languages: English/Spanish

    (412) 647–2345

    200 Lothrop Street

    Pittsburgh, Pennsylvania 15213-2536

    Read More

    UPMC Shadyside

    Languages: English/Spanish

    (412) 623-2121

    5230 Centre Ave

    Pittsburgh, Pennsylvania 15232

    Read More
  • Publications & Memberships

    Dr. Weijing Sun has contributed to 3 publications.

    A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma

    Ciuleanu T, Bazin I, Lungulescu D, Miron L, Bondarenko I, Deptala A, Rodriguez-Torres M, Giantonio B, Fox NL, Wissel P, Egger J, Ding M, Kalyani RN, Humphreys R, Gribbin M, Sun W

    See more >>

    A phase II trial of gemcitabine, irinotecan and panitumumab in advanced and metastatic cholangiocarcinoma

    Sohal DS, Mykulowycz K, Uehara T, Teitelbaum UR, Damjanov N, Giantonio BJ, Carberry M, Wissel P, Jacobs-Small M, O'Dwyer PJ, Sepulveda A, Sun W

    See more >>

    Two phase I studies of concurrent radiation therapy with continuous-infusion 5-Xuorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas

    Sun W, Metz J, Gallagher M, O'Dwyer PJ, Whittington R, Giantonio B, Haller DG

    See more >>


    American Association for Cancer Research

    American Society of Clinical Oncology